Theresa Mercado. // photo courtesy Vinegar Syndrome A screening of Vinegar Syndrome’s restoration of Blood Beat shows at ...
Shares of Regeneron Pharmaceuticals (NASDAQ: REGN), a biotech giant, have been southbound over the past two years as the ...
Regeneron Pharmaceuticals, Inc. REGN announced that the European Commission (EC) has approved label expansion of its PD-1 inhibitor Libtayo (cemiplimab). The EC approved Libtayo as an adjuvant ...
TARRYTOWN, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has extended the target action dates ...
TARRYTOWN, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has extended the target action dates ...
Hello! Thank you for all of your great work! I am closely following the Seurat 5.2 Visium HD vignette while working with one of 10x's publicly available Visium HD lung datasets and get an unexpected ...
GM has issued an emission recall for certain units of the 2025 Chevy Silverado 1500 and 2025 Chevy Silverado HD pickup trucks that were potentially produced with incorrect Vehicle Emissions Control ...
CEO Leonard Schleifer highlighted 10% revenue growth in Q4 2024, attributed to strong performance from Dupixent, Libtayo, and EYLEA HD. He emphasized the acceleration in EYLEA HD uptake expected in ...
GM has issued a Customer Satisfaction Program for some units of the 2024 GMC Sierra HD that were produced with incorrect values printed on the trailering label, potentially providing owners with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback